Perspective Therapeutics holds routine annual meeting, elects six directors for one-year terms

Filed May 27, 2026 · Period ending May 27, 2026 · ~1 min read

Key Changes

• low

  Six directors elected to serve until 2027 annual meeting: Lori Woods, Heidi Henson, Maya Martinez-Davis, Frank Morich, Johan Spoor, and Robert Williamson. All nominees received majority support with no contested seats.

  Item 5.07 verify on EDGAR →
• low

  Shareholders ratified WithumSmith+Brown as independent auditor for fiscal 2026 with 97.6 million votes in favor, representing overwhelming approval of the audit firm selection.

  Item 5.07 verify on EDGAR →
• low

  Board adopted annual frequency for say-on-pay votes after shareholders expressed preference with 76.5 million votes. Executive compensation will be subject to advisory shareholder vote each year going forward.

  Item 5.07 verify on EDGAR →